Literature DB >> 23897170

Cancer: The effect of radioiodine therapy after total thyroidectomy.

Andreas Bockisch1, Sandra Rosenbaum-Krumme.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23897170     DOI： 10.1038/nrendo.2013.153

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

1.  European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium.

Authors:  Furio Pacini; Martin Schlumberger; Henning Dralle; Rossella Elisei; Johannes W A Smit; Wilmar Wiersinga
Journal:  Eur J Endocrinol       Date:  2006-06       Impact factor: 6.664

2.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

3.  Low- or high-dose radioiodine remnant ablation for differentiated thyroid carcinoma: a meta-analysis.

Authors:  Weiwei Cheng; Chao Ma; Hongliang Fu; Jianing Li; Suyun Chen; Shuqi Wu; Hui Wang
Journal:  J Clin Endocrinol Metab       Date:  2013-02-22       Impact factor: 5.958

4.  Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.

Authors:  C Durante; N Haddy; E Baudin; S Leboulleux; D Hartl; J P Travagli; B Caillou; M Ricard; J D Lumbroso; F De Vathaire; M Schlumberger
Journal:  J Clin Endocrinol Metab       Date:  2006-05-09       Impact factor: 5.958

Review 5.  Follow-up of differentiated thyroid carcinoma.

Authors:  L Pagano; M Klain; M Pulcrano; G Angellotti; F Pasano; M Salvatore; G Lombardi; B Biondi
Journal:  Minerva Endocrinol       Date:  2004-12       Impact factor: 2.184

6.  The results of selective use of radioactive iodine on survival and on recurrence in the management of papillary thyroid cancer, based on Memorial Sloan-Kettering Cancer Center risk group stratification.

Authors:  Iain J Nixon; Ian Ganly; Snehal G Patel; Frank L Palmer; Monica M Di Lorenzo; Ravinder K Grewal; Steven M Larson; R Michael Tuttle; Ashok Shaha; Jatin P Shah
Journal:  Thyroid       Date:  2013-06       Impact factor: 6.568

7.  Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients.

Authors:  M Brassard; I Borget; A Edet-Sanson; A-L Giraudet; O Mundler; M Toubeau; F Bonichon; F Borson-Chazot; L Leenhardt; C Schvartz; C Dejax; I Brenot-Rossi; M-E Toubert; M Torlontano; E Benhamou; M Schlumberger
Journal:  J Clin Endocrinol Metab       Date:  2011-03-09       Impact factor: 5.958

8.  Prognostic value of the sixth edition AJCC/UICC TNM classification for differentiated thyroid carcinoma with extrathyroid extension.

Authors:  Nobuyuki Wada; Hirotaka Nakayama; Nobuyasu Suganuma; Yoshihiko Masudo; Yasushi Rino; Munetaka Masuda; Toshio Imada
Journal:  J Clin Endocrinol Metab       Date:  2006-10-31       Impact factor: 5.958

9.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.

Authors:  E L Mazzaferri; S M Jhiang
Journal:  Am J Med       Date:  1994-11       Impact factor: 4.965

Review 10.  Controversies in primary treatment of low-risk papillary thyroid cancer.

Authors:  Donald S A McLeod; Anna M Sawka; David S Cooper
Journal:  Lancet       Date:  2013-03-22       Impact factor: 79.321
  10 in total
  2 in total

1.  Prognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative (124)I-NaI-PET/CT in patients with papillary thyroid cancer.

Authors:  Amir Sabet; Ina Binse; Hong Grafe; Samer Ezziddin; Rainer Görges; Thorsten D Poeppel; Andreas Bockisch; Sandra J Rosenbaum-Krumme
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-04-27       Impact factor: 9.236

2.  Review of survival rates 20-years after conservative surgery for papillary thyroid carcinoma.

Authors:  Abrão Rapoport; Otávio Alberto Curioni; Ali Amar; Rogério Aparecido Dedivitis
Journal:  Braz J Otorhinolaryngol       Date:  2015-06-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.